seaspine
-
Spine
SeaSpine Announces Full Commercial Launch of the Reef™ TO (TLIF Oblique) Interbody System
CARLSBAD, Calif., March 01, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Spine
SeaSpine Announces Limited Commercial Launch of WaveForm™ TA (TLIF Articulating) 3D-Printed Interbody System
CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
SeaSpine Reports Granting of Inducement Awards
CARLSBAD, Calif., Feb. 05, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Regulatory
SeaSpine Announces FDA 510(k) Clearance for Amended Indication for NanoMetalene® Surface Technology
CARLSBAD, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Spine
SeaSpine Announces Limited Commercial Launch of Meridian™ ALIF System with Reef™ A Interbody
CARLSBAD, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Spine
SeaSpine Announces Limited Commercial Launch of its Admiral™ ACP System
CARLSBAD, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical…
Read More » -
Financial
SeaSpine Reports Third Quarter 2020 Financial Results
CARLSBAD, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Biologics
SeaSpine Announces Publication of Results from a Cellular Bone Graft Study in The Journal of Bone and Joint Surgery (JBJS)
CARLSBAD, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
SeaSpine Provides Preliminary Results for Third Quarter 2020 and Revenue Guidance for Fourth Quarter 2020
CARLSBAD, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
SeaSpine Reports Granting of Inducement Awards
CARLSBAD, Calif., Oct. 02, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Biologics
SeaSpine Announces Limited Commercial Launch of WaveForm C 3D-Printed Interbody Implant System
CARLSBAD, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Spine
SeaSpine® Announces Limited Commercial Launch of Explorer™ TO Expandable Interbody Device
CARLSBAD, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
SeaSpine Reports Second Quarter 2020 Financial Results
CARLSBAD, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
SeaSpine Reports First Quarter 2020 Financial Results
CARLSBAD, Calif., May 06, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
SeaSpine® and 7D Surgical Announce Entry into a Strategic Alliance Agreement to Distribute 7D Surgical’s Flagship Machine-Vision Image Guided Surgery (MvIGS) Platform
CARLSBAD, Calif. and TORONTO, Feb. 07, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company…
Read More »